{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:38:37Z","timestamp":1774535917649,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clinimag.2024.110097","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:46:47Z","timestamp":1706618807000},"page":"110097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics"],"prefix":"10.1016","volume":"108","author":[{"given":"Byeong Geun","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyun","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeun-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hye","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Ah.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeseung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinimag.2024.110097_bb0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.clinimag.2024.110097_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2468-1253(20)30091-1","article-title":"Redefining non-alcoholic fatty liver disease: what's in a name?","volume":"5","author":"The Lancet Gastroenterology H","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.clinimag.2024.110097_bb0030","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","article-title":"Differential clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinimag.2024.110097_bb0035","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.clinimag.2024.110097_bb0040","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.clinimag.2024.110097_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","author":"European Association for the Study of the L","year":"2016","journal-title":"Obes Facts"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110097_bb0055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinimag.2024.110097_bb0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110097_bb0065","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What\u2019s in a name?","volume":"40","author":"Fouad","year":"2020","journal-title":"Renaming \u201cNAFLD\u201d to \u201cMAFLD\u201d Liver Int"},{"issue":"2","key":"10.1016\/j.clinimag.2024.110097_bb0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1148\/radiol.2016161042","article-title":"Tumefactive gallbladder sludge at US: prevalence and clinical importance","volume":"283","author":"Kim","year":"2017","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.clinimag.2024.110097_bb0075","first-page":"5453","article-title":"Sonographic assessment of fatty liver: intraobserver and interobserver variability","volume":"7","author":"Cengiz","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"22","key":"10.1016\/j.clinimag.2024.110097_bb0080","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.3748\/wjg.v20.i22.6821","article-title":"Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease","volume":"20","author":"Khov","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"48","key":"10.1016\/j.clinimag.2024.110097_bb0085","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of liver cirrhosis","volume":"20","author":"Soresi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinimag.2024.110097_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13244-014-0336-2","article-title":"Ultrasound in chronic liver disease","volume":"5","author":"Gerstenmaier","year":"2014","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0009-9260(05)80350-2","article-title":"Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease","volume":"43","author":"Joseph","year":"1991","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0100","first-page":"11","article-title":"Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS","volume":"34","author":"Claudon","year":"2013","journal-title":"Ultraschall Med"},{"issue":"1","key":"10.1016\/j.clinimag.2024.110097_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.clinimag.2024.110097_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","article-title":"The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis","volume":"48","author":"Jinjuvadia","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110097_bb0115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinimag.2024.110097_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070664","article-title":"Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.clinimag.2024.110097_bb0125","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s12072-021-10205-7","article-title":"Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy","volume":"15","author":"Oh","year":"2021","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110097_bb0130","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.26072","article-title":"Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?","volume":"57","author":"van der Poorten","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinimag.2024.110097_bb0135","first-page":"1295","article-title":"Liver biopsy complications and routine ultrasound","volume":"91","author":"Stotland","year":"1996","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707124000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707124000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:52:08Z","timestamp":1760269928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707124000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"alternative-id":["S0899707124000275"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2024.110097","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2024.110097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110097"}}